Skip to main content
Article
Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas
CNS oncology (2014)
  • Vincent A van Vugt, University of California, San Diego
  • David E Piccioni, University of California, San Diego
  • Bradley D Brown, University of California, San Diego
  • Tiffany Brown, University of California, San Diego
  • Marlon G Saria, University of California, San Diego
  • Tiffany Juarez, University of California, San Diego
  • Santosh Kesari, University of California, San Diego
Publication Date
July 1, 2014
DOI
10.2217/cns.14.29
Citation Information
Vincent A van Vugt, David E Piccioni, Bradley D Brown, Tiffany Brown, et al.. "Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas" CNS oncology Vol. 3 Iss. 4 (2014) p. 257 - 265
Available at: http://works.bepress.com/marlon-saria/30/